17,261 trials
Recurrent Lymphoepithelioma of the Nasopharynx · Recurrent Squamous Cell Carcinoma of the Nasopharynx · Stage IV Lymphoepithelioma of the Nasopharynx
Primary: Clinical Benefit Rate — 54.5 percentage of participants
Cytomegalovirus (CMV)
Primary: Number of Participants With Confirmed Undetectable Plasma Cytomegalovirus (CMV) Within 6 Weeks — 28; 25; 27 participants
Pancreatic Cancer
Primary: Overall Survival at 18 Months — 63 percentage of participants
Polycystic Ovary Syndrome
Primary: Live Birth Rate — 13; 5; 12 participants — p=0.06
Melanoma
Primary: Number of Participants With Adverse Events — 3; 3; 0; 0 participants
Posttraumatic Stress Disorder
Primary: Change in PTSD Symptoms as Measured by the PCL — -7.33; -2.13 Units on a scale
Chronic Kidney Disease · Hypertension · Hyperkalemia
Primary: Least Squares Mean Change in Serum Potassium From Baseline to Week 4 or Time of First Titration for Each Individual Starting Dose Group — -0.35; -0.51; -0.55; -0.87…
Aging
Primary: Qualitative Changes in Dermal and Sub Dermal Collagen and Cellularity 30 Minutes After Treatment With Platelet Rich Fibrin Matrix — 0 %specimen with >25%new collagen/HPF
Atopic Dermatitis
Primary: Change From Baseline in Eczema Area and Severity Index (EASI) — -8.65; -6.95 Score on a scale
Colorectal Cancer
Primary: Number of Participants With a >20% Decrease in Positron Emission Tomography (PET)-Assessed Tumor Glucose Metabolism: Fluorodeoxyglucose (FDG) Standardized Uptake Value…
Hypogonadism
Primary: Percentage of Subjects Achieving a 24 Hour Average Total Serum Testosterone Concentration (Cavg,0-24h) in the Range of 300 to 1050 ng/dL After 15 Days of Treatment With…
Acute Cerebrovascular Accident · Cerebral Edema
Primary: Modified Rankin Score
Epilepsy
Primary: Number of Subjects That Report at Least One Treatment-emergent Adverse Event During the Study (Approximately 13 Weeks) — 14; 19; 9 participants
Hyperkalemia · Heart Failure
Primary: Change From Baseline in Serum Potassium to the End of the 28-day Treatment Period. — -0.21; 0.23 mEq/L — p=< 0.001
Hypoparathyroidism
Primary: Serum Calcium Level — 2; 1.92 mmol/liter